These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38584032)

  • 1. Prevalence of celiac disease in systemic lupus erythematosus, sjogren syndrome and systemic sclerosis: A systematic review and meta-analysis.
    Beas R; Altamirano-Farfan E; Izquierdo-Veraza D; Norwood DA; Riva-Moscoso A; Godoy A; Montalvan-Sanchez EE; Ramirez M; Guifarro DA; Kitchin E; Fischer M; Kurada S
    Dig Liver Dis; 2024 Sep; 56(9):1475-1482. PubMed ID: 38584032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.
    Andraos R; Ahmad A; Eriksson P; Dahlström Ö; Wirestam L; Dahle C; Hesselstrand R; Bengtsson AA; Jönsen A; Andréasson K; Sjöwall C
    Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
    Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X
    Rheumatology (Oxford); 2007 Feb; 46(2):321-6. PubMed ID: 16877466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
    Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
    Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
    Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
    Gkoutzourelas A; Liaskos C; Simopoulou T; Katsiari C; Efthymiou G; Scheper T; Meyer W; Tsirogianni A; Tsigalou C; Dardiotis E; Daoussis D; Sakkas LI; Bogdanos DP
    Rheumatol Int; 2020 Oct; 40(10):1689-1699. PubMed ID: 32681396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease.
    Fauchais AL; Martel C; Gondran G; Lambert M; Launay D; Jauberteau MO; Hachulla E; Vidal E; Hatron PY
    Autoimmun Rev; 2010 Jul; 9(9):595-9. PubMed ID: 20457283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis.
    Yao Q; Altman RD; Wang X
    J Clin Rheumatol; 2012 Jan; 18(1):28-32. PubMed ID: 22157271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.
    Bartoloni E; Bistoni O; Alunno A; Cavagna L; Nalotto L; Baldini C; Priori R; Fischetti C; Fredi M; Quartuccio L; Carubbi F; Montecucco C; Doria A; Mosca M; Valesini G; Franceschini F; De Vita S; Giacomelli R; Mirabelli G; Bini V; Gabrielli A; Catassi C; Gerli R
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 31010199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
    van der Kroef M; van den Hoogen LL; Mertens JS; Blokland SLM; Haskett S; Devaprasad A; Carvalheiro T; Chouri E; Vazirpanah N; Cossu M; Wichers CGK; Silva-Cardoso SC; Affandi AJ; Bekker CPJ; Lopes AP; Hillen MR; Bonte-Mineur F; Kok MR; Beretta L; Rossato M; Mingueneau M; van Roon JAG; Radstake TRDJ
    Eur J Immunol; 2020 Jan; 50(1):119-129. PubMed ID: 31424086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis.
    Horimoto AM; Silveira AF; da Costa IP
    Rev Bras Reumatol Engl Ed; 2016; 56(4):314-22. PubMed ID: 27476624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
    Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
    Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum CA125 in progressive systemic sclerosis with pleural effusion.
    Kimura K; Ezoe K; Yokozeki H; Katayama I; Nishioka K
    J Dermatol; 1995 Jan; 22(1):28-31. PubMed ID: 7897020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of autoantibodies to various Ro60 epitopes in the decrease of lymphocytes seen in systemic lupus erythematosus and primary Sjögren's syndrome.
    Shuai ZW; Huang Y; Zhang L; Cai J; Li M
    Genet Mol Res; 2015 Aug; 14(3):10096-102. PubMed ID: 26345947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.
    Lakota K; Thallinger GG; Sodin-Semrl S; Rozman B; Ambrozic A; Tomsic M; Praprotnik S; Cucnik S; Mrak-Poljsak K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Czirják L; Varjú C; Steiner G; Aringer M; Stamenkovic B; Distler O; Matucci-Cerinic M; Kveder T
    Arthritis Res Ther; 2012 Jan; 14(1):R2. PubMed ID: 22226402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.